Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
about
The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic VariantsIdentification of the core regulators of the HLA I-peptide binding processNNAlign: a platform to construct and evaluate artificial neural network models of receptor-ligand interactions.Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions.The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine DesignHLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.Evolution of MHC-based technologies used for detection of antigen-responsive T cellsA Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expressionImmunoinformatics and epitope prediction in the age of genomic medicine.Citrullination only infrequently impacts peptide binding to HLA class II MHCNetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets.Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics.The role of neoantigens in response to immune checkpoint blockade.Computational genomics tools for dissecting tumour-immune cell interactions.Current tools for predicting cancer-specific T cell immunity.Mycobacterium tuberculosis Complex Exhibits Lineage-Specific Variations Affecting Protein Ductility and Epitope Recognition.Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.Discovery of T-cell Driven Subunit Vaccines from Zika Virus Genome: An Immunoinformatics Approach.'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization.Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.Improved methods for predicting peptide binding affinity to MHC class II molecules.An automated benchmarking platform for MHC class II binding prediction methods.Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report.Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components.Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.Homology modeling and epitope prediction of Der f 33.The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile.Distinct HLA associations of LGI1 and CASPR2-antibody diseases.Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions.Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance.
P2860
Q28396379-8389BE60-EE47-47AF-A830-0AB3ECA1DF5AQ29048598-D963D1A8-E13C-4D78-96A0-EFD6206F782BQ30008748-89FCAFB8-7F01-4ACD-81E2-F394498BD0CCQ30391717-BE6A0899-F637-4A84-99C0-A6293795AF15Q30400430-5CE8E7FB-61CE-4C55-A3E5-571BA717A6CDQ33437901-2B2C0B6D-0F15-4017-9870-183E5925F4A2Q33607055-7A472CB0-0D3C-40E1-A50A-F611E3F57CABQ36011959-3CF25368-521B-40A9-A9A2-E9CBC1F4C77BQ36301828-C16099BE-F3A9-4226-9478-F646A245399DQ36304147-47EAC3C5-D0D6-442F-A351-8AD8CE4F94D7Q36365784-732F786C-3114-4A27-9BD3-F293832916FFQ36742441-E2CEE1EA-F372-48D3-A744-CA1229633573Q38789472-D5218D56-EB90-4B45-B215-0A4943F9B2B8Q38798968-477992FC-FDCA-4D35-AA21-70C952782E04Q38885361-24BCE749-8072-4051-8F56-3F390AD9605CQ38953021-4C4E410F-5601-4AAF-8164-61BFF3D0D2CEQ41089843-F720D9A1-70D5-4DF3-BB0E-DA7E30C00BF0Q41358442-EE560283-A6BF-4317-B904-5924B1B5930BQ41410098-B5BB755A-8AA1-4F9B-B55B-26EFF1C5FD72Q41487863-F744FDA6-2F7A-475D-9E40-78B0420910F7Q42317060-8E161499-D24E-4B1F-9B6F-39FC5D343E8EQ43046894-87FD6DAA-65BC-4DDC-B1E1-1FB012198DAAQ45718710-D52F471F-17FB-4067-87CC-0FD90A3458DBQ45873080-300856E3-BFDE-4BFB-B69F-7F61D42F3A1FQ45947295-C7CEE647-DBB4-4F7D-B216-E36AF752C988Q47189829-CA4E1E26-55C8-4884-9265-D27CCEB4198AQ47243904-B817C0A2-C0B0-4943-B5BA-97756392A1C9Q47656863-D1144568-7D13-48DB-938E-C1B91111FC85Q47758596-E9532F66-89E4-4419-B983-E44680E1DBEEQ49836890-D3592335-BE5B-43E7-86DC-12C4DDCD5481Q50057949-FF9A636A-30EA-419B-B75A-9BD1F40E150AQ52571067-C3346CEE-1B46-48EE-AA45-D0CBAF84AD9EQ54962720-D3AD4BBC-A801-4E77-A189-C26FD411B616Q55067919-4AB72ED2-3F28-4C77-A41A-8C065A6B59D5Q55097685-924BFA9E-DA0B-4B4F-9283-C97B65E621D1Q55102636-9E0DB684-E9F1-402C-9C6C-806ECF746647Q55380572-8F82688D-184E-4C57-B5FA-36358CE5865EQ55457015-4C4C3F96-3B00-4988-9E04-E698CFEF8217Q55498545-73BCAC8F-EE04-41A8-8D38-DB48590F115CQ55605287-9BBA87D9-2F63-4D3B-B673-70D3038630A8
P2860
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Accurate pan-specific predicti ...... d binding core identification.
@ast
Accurate pan-specific predicti ...... d binding core identification.
@en
type
label
Accurate pan-specific predicti ...... d binding core identification.
@ast
Accurate pan-specific predicti ...... d binding core identification.
@en
prefLabel
Accurate pan-specific predicti ...... d binding core identification.
@ast
Accurate pan-specific predicti ...... d binding core identification.
@en
P2093
P2860
P1433
P1476
Accurate pan-specific predicti ...... d binding core identification.
@en
P2093
Edita Karosiene
Massimo Andreatta
Michael Rasmussen
Søren Buus
P2860
P2888
P304
P356
10.1007/S00251-015-0873-Y
P407
P577
2015-09-29T00:00:00Z